GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » H. Lundbeck AS (OCSE:HLUN B) » Definitions » Other Stockholders Equity

H. Lundbeck AS (OCSE:HLUN B) Other Stockholders Equity : kr1,111 Mil (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is H. Lundbeck AS Other Stockholders Equity?

H. Lundbeck AS's Other Stockholders Equity for the quarter that ended in Sep. 2024 was kr1,111 Mil.

H. Lundbeck AS's quarterly Other Stockholders Equity increased from Mar. 2024 (kr1,285 Mil) to Jun. 2024 (kr1,289 Mil) but then declined from Jun. 2024 (kr1,289 Mil) to Sep. 2024 (kr1,111 Mil).

H. Lundbeck AS's annual Other Stockholders Equity increased from Dec. 2021 (kr712 Mil) to Dec. 2022 (kr1,594 Mil) but then declined from Dec. 2022 (kr1,594 Mil) to Dec. 2023 (kr1,172 Mil).


H. Lundbeck AS Other Stockholders Equity Historical Data

The historical data trend for H. Lundbeck AS's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

H. Lundbeck AS Other Stockholders Equity Chart

H. Lundbeck AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 807.00 229.00 712.00 1,594.00 1,172.00

H. Lundbeck AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,556.00 1,172.00 1,285.00 1,289.00 1,111.00

H. Lundbeck AS Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


H. Lundbeck AS Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of H. Lundbeck AS's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


H. Lundbeck AS Business Description

Address
Ottiliavej 9, Valby, DNK, 2500
Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.

H. Lundbeck AS Headlines

No Headlines